中华眼外伤职业眼病杂志
中華眼外傷職業眼病雜誌
중화안외상직업안병잡지
CHINESE JOURNAL OF OCULAR TRAUMA AND OCCUPATIONAL EYE DISEASE
2011年
4期
289-291
,共3页
鼻泪管,人工%植入%丝裂霉素C
鼻淚管,人工%植入%絲裂黴素C
비루관,인공%식입%사렬매소C
Mitomycin C%Nasolacrimal duct%Artificial%Implatation
目的 探讨丝裂霉素C(MMC)对提高人工鼻泪管植入术治疗慢性泪囊炎疗效的意义.方法 89例(98眼)慢性泪囊炎分为治疗组和对照组.对照组采用人工鼻泪管植入术,而治疗组在人工鼻泪管植入术中及术后7 d使用0.02%MMC 0.5 mL注入泪道.结果 术后随访10～12个月,治疗组36眼中有35眼泪道冲洗通畅,对照组62眼中有53眼泪道冲洗通畅,差异有统计学意义(P=0.004).结论 在人工鼻泪管植入术中、术后应用MMC是一种能提高远期疗效的安全、有效的辅助措施.
目的 探討絲裂黴素C(MMC)對提高人工鼻淚管植入術治療慢性淚囊炎療效的意義.方法 89例(98眼)慢性淚囊炎分為治療組和對照組.對照組採用人工鼻淚管植入術,而治療組在人工鼻淚管植入術中及術後7 d使用0.02%MMC 0.5 mL註入淚道.結果 術後隨訪10～12箇月,治療組36眼中有35眼淚道遲洗通暢,對照組62眼中有53眼淚道遲洗通暢,差異有統計學意義(P=0.004).結論 在人工鼻淚管植入術中、術後應用MMC是一種能提高遠期療效的安全、有效的輔助措施.
목적 탐토사렬매소C(MMC)대제고인공비루관식입술치료만성루낭염료효적의의.방법 89례(98안)만성루낭염분위치료조화대조조.대조조채용인공비루관식입술,이치료조재인공비루관식입술중급술후7 d사용0.02%MMC 0.5 mL주입루도.결과 술후수방10～12개월,치료조36안중유35안루도충세통창,대조조62안중유53안루도충세통창,차이유통계학의의(P=0.004).결론 재인공비루관식입술중、술후응용MMC시일충능제고원기료효적안전、유효적보조조시.
Objective To explore the influence of Mitomycin C(MMC)in artificial nasolacrimal stent placement to treat chronic dacryocystitis.Methods 89 cases(98 eyes)of chronic dacryocystitis were divided into Mitomycin C group and control group.In the former,0.5 mL of MMC(0.02%)Was injected into the lacrimal duct during the operation and postoperation,and the latter with no MMC.Results All cases were followed-up for 10～12 months in the postopemtion.Lacrimal drainage systems were patent in 35/36 eyes in MMC group,and 53/62 eyes in control group.There Was a statistically significant difference between MMC group and control group(P=0.004,Fisher's Exact Test).Conclusion MMC in artificial nasolacrimal stent placement postoperafively seems a safe and effective adjuvant procedure and can maintain higher long-term Success rate.
